• Technology and energy remain the market’s strongest-performing sectors year-to-date
  • S&P 500 technology companies delivered nearly 30 per cent revenue growth and 54 per cent earnings growth in Q1
  • Fund managers now view long semiconductors as the most overcrowded trade, signalling potential caution ahead

Strong tech earnings continue to drive market leadership

Technology continues to dominate market leadership in 2026, and according to Bruce Campbell, the earnings data may justify much of the enthusiasm.

In this week’s Markets in Motion, Campbell highlights how both technology and energy have emerged as the top-performing sectors year-to-date. While concerns around valuation remain common, the underlying earnings growth tells a different story.

This article is being disseminated on behalf of a third-party issuer and is intended for informational purposes only.

Q1 revenue growth for the S&P 500 technology sector came in near 30 per cent, while earnings growth surged roughly 54 per cent year-over-year — significantly outpacing most other sectors. By comparison, healthcare has lagged both fundamentally and in market performance, while energy earnings are expected to strengthen later in the year as higher oil prices begin flowing through results.

Campbell also points to valuation metrics like the PEG ratio, which compares price-to-earnings against growth rates. Despite claims that markets are becoming excessively expensive, current growth levels suggest valuations may still be more reasonable than many investors assume — particularly in technology.

The takeaway: strong earnings momentum remains supportive, but investors should avoid becoming complacent as leadership narrows.

Watch the full video above or on YouTube, and get involved in the conversation by leaving your comments and engaging in the forums.

Join the discussion: Check out Stockhouse’s stock forums and message boards.

More From The Market Online

Small-cap Canadian healthcare firm expands AI-screening at home and abroad

Diagnos (TSXV:ADK) uses AI through its CARA platform to help detect eye diseases like diabetic retinopathy & age-related macular degeneration

This healthtech company improves neurological care with AI

CeriBell is a healthtech company applying AI to neurological critical care, vastly improving diagnoses versus legacy technology.

Market Open: Amazon and Alphabet plunge, Cohere set to scale | Oct 30

TSX futures slipped before Friday's market open, with investors digesting the fallout of the Bank of Canada's rate hike on Wednesday.

Pharma as a defensive alternative: Eli Lilly, Formycon and GSK in focus

This year we have repeatedly seen major rotations, particularly in the US equity markets. When AI stocks weakened, other sectors, such as utilities and…